Background

Manfred Mosk Ph.D. has been the President of Technomedics Management & Systems, Inc., a privately held healthcare economics consulting firm, since 1994. Dr. Mosk served as Chairman of Duska Scientific since 1999 and part-time interim Chief Executive Officer during 2003. Dr. Mosk was the co-founder, former President, Chief Executive Officer and director of Medco Research, Inc. from approximately 1983 to 1992, when he voluntarily retired from these positions. Medco was ... subsequently acquired by King Pharmaceuticals, Inc. Under Dr. Mosk's leadership, Medco acquired licenses, raised funds, became a public company and developed the first-ever approved and marketed adenosine-based drug in the U.S. He served as a Non-Executive Chairman and Director of Duska Therapeutics, Inc. from August 2004 to December 7, 2005. Dr. Mosk served as Non Executive Chairman of Duska Scientific since January 1, 2004 and as Director. He served as Non-Executive Chairman of Duska Therapeutics, Inc. since the merger with Duska Scientific. He serves as a Director of Spectral Molecular Technologies, Inc., a medical optical imaging research and development company. He serves on the Board of Advisors of GeoVax, Inc. and Spectrum Laboratories, Inc. He rejoined the Board and served again as a director of Medco from approximately 1995 to 1996. He served as a Member of Advisory Board of Duska Therapeutics Inc. He serves on the Boards of Directors of UCLA's Jonsson Cancer Center Foundation, The University Kidney Disease Research Associates at the University of Southern California School of Medicine. Dr. Mosk also serves on the Executive Committee of the Board of Governors of the Cedars Sinai Medical Center. He previously served on the Board of Directors of Arbios Systems, Inc. and the California State University (system-wide) Foundation and on the Board of Visitors of the University of California, College of Medicine, at Irvine, California. Dr. Mosk holds B.S., M.S. and Ph.D. degrees in business administration from The California State University and The California Western University.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.